ASCO Gastrointestinal Cancer Symposium | Conference

Updated Trial for PSMA-Targeted Therapy in Metastatic Prostate Cancer Excites
February 22, 2019

The latest trial results are based on a larger patient population and were reported at the 2019 ASCO Genitourinary Cancers Symposium.

ARCHES Trial “Changes Practice” for Metastatic Hormone-Sensitive Prostate Cancer
February 21, 2019

The results of the double-blind, phase III trial were presented at the 2019 ASCO Genitourinary Cancers Symposium.

Pembrolizumab Plus Axitinib vs Standard Treatment For mRCC
February 13, 2019

Treatment with pembrolizumab plus axitinib improved response and survival compared with sunitinib in patients with advanced, or metastatic clear-cell renal cell carcinoma.